Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

Abstract
Aims We investigated the predictive value of plasma concentration of asymmetrical dimethylarginine (ADMA) on clinical outcome in patients undergoing

This publication has 0 references indexed in Scilit: